References
- Ertel V, Früh M, Guenther A, et al. Thymoma with molecularly verified "conversion" to T lymphoblastic leukemia/lymphoma over 9 years. Leuk Lymphoma. 2013;54:2765–2768.
- Meier VS, Rufle A, Gudat F. Simultaneous evaluation of T- and B-cell clonality, t(11;14) and t(14;18), in a single reaction by a four-color multiplex polymerase chain reaction assay and automated high-resolution fragment analysis. A method for the rapid molecular diagnosis of lymphoproliferative disorders applicable to fresh frozen and formalin-fixed, paraffin-embedded tissues, blood, and bone marrow aspirates. Am J Pathol. 2001;159:2031–2043.
- Adam P, Hakroush S, Hofmann I, et al. Thymoma with loss of keratin expression (and giant cells): a potential diagnostic pitfall. Virchows Arch. 2014;465:313–320.
- Menter T, Gasser A, Juskevicius D, et al. Diagnostic utility of the germinal center-associated markers GCET1, HGAL, and LMO2 in hematolymphoid neoplasms. Appl Immunohistochem Mol Morphol. 2015;23:491–498.
- Jegalian AG, Bodo J, Hsi ED. NOTCH1 intracellular domain immunohistochemistry as a diagnostic tool to distinguish T-lymphoblastic lymphoma from thymoma. Am J Surg Pathol. 2015;39:565–572.
- Juskevicius D, Lorber T, Gsponer J, et al. Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis. Leukemia. 2016;30:2385–2395.
- Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306:269–271.
- Martinez GS, Ross JA, Kirken RA. Transforming mutations of Jak3 (A573V and M511I) show differential sensitivity to selective Jak3 inhibitors. Clin Cancer Drug. 2016;3:131–137.
- Hornakova T, Springuel L, Devreux J, et al. Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors. Haematologica. 2011;96:845–853.
- Obermann EC, Mueller N, Rufle A, et al. Clonal relationship of classical hodgkin lymphoma and its recurrences. Clin Cancer Res. 2011;17:5268–5274.
- Ito J, Yoshida A, Maeshima AM, et al. Concurrent thymoma, thymic carcinoma, and T lymphoblastic leukemia/lymphoma in an anterior mediastinal mass. Pathol Res Pract. 2015;211:693–696.
- Petrini I, Meltzer PS, Kim IK, et al. A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. Nat Genet. 2014;46:844–849.
- Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010;5:S260–S265.
- Travis LB, Boice JD, Jr, Travis WD. Second primary cancers after thymoma. Int J Cancer. 2003;107:868–870.
- Giri S, Chi M, Johnson B, et al. Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis. Leuk Res. 2015;39:1342–1346.